Miranda Toledano is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Apr 2019: Trigr Therapeutics, Inc. (Irvine, CA — pharmaceuticals — 2019; $5M reported sold to 3 investors).
What this means One deal on file with the SEC, filed Apr 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside George Uy (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Miranda. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Miranda Toledano and found 4 differences: Form D filed 41 days after the first sale; Same name, different state: "Miranda Toledano" (L3) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.